FDA Mandates New Warning for GLP-1 Drugs, Including Ozempic, Regarding Rare Eye Condition
Rapid Read

FDA Mandates New Warning for GLP-1 Drugs, Including Ozempic, Regarding Rare Eye Condition

What's Happening? The Food and Drug Administration (FDA) has mandated that Ozempic and all other GLP-1 drugs sold in the United States must now include a warning about a rare eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION). This condition, often described as a 'stroke
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.